Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 267 | 183 | 371 | 702 | 541 |
Gross Profit | 267 | 183 | 371 | 702 | 541 |
Operating Expenses | 1,168 | 3,207 | 3,373 | 3,535 | 3,135 |
Operating Income | -901 | -3,024 | -3,002 | -2,833 | -2,593 |
Interest Expense | 1 | 211 | -25 | 158 | 34 |
Other Income | 61 | 15 | 15 | 15 | 26 |
Pre-tax Income | -840 | -3,219 | -2,962 | -2,976 | -2,601 |
Net Income Continuous | -840 | -3,219 | -2,962 | -2,976 | -2,601 |
Net Income Discontinuous | -2,689 | N/A | N/A | N/A | N/A |
Net Income | $-3,529 | $-3,219 | $-2,962 | $-2,976 | $-2,601 |
EPS Basic Total Ops | -4.12 | -7.99 | -0.20 | -5.34 | -5.18 |
EPS Basic Continuous Ops | -1.03 | -8.72 | -0.23 | -4.95 | -5.10 |
EPS Basic Discontinuous Ops | -3.31 | N/A | N/A | N/A | N/A |
EPS Diluted Total Ops | -4.12 | -7.99 | -0.20 | -5.34 | -5.18 |
EPS Diluted Continuous Ops | -1.03 | -8.72 | -0.23 | -4.95 | -5.10 |
EPS Diluted Discontinuous Ops | -3.31 | N/A | N/A | N/A | N/A |
EPS Diluted Before Non-Recurring Items | -1.37 | -4.06 | -4.07 | -5.00 | -5.20 |
EBITDA(a) | $-820 | $-2,940 | $-2,914 | $-2,747 | $-2,511 |